Challenges and Benefits of Patient-Based Phase I Trials

Contributor:  Pharma IQ
Posted:  05/05/2011  12:00:00 AM EDT
Rate this Article: (4.2 Stars | 13 Votes)

Pharma IQ held a Q&A session with Dr. James Dow, Director of Clinical Pharmacology & DMPK, (OSI) Prosidion  to gain a few insights into phase I clinical development and patient-based phase I trials.

How do you feel the clinical trial landscape changed in the past 5 years?

Clearly the trend to include patients in early api_key: yyk77b5593bu scope:r_basicprofile r_emailaddress authorize: false

To continue viewing this content please fill out the form below and become an IQ member.

First Name*
Last Name*
E-mail*
Phone*
Job Title*
Company*
Country
State
Username*
Password*
Confirm Password*
Pharma IQ Contributor:   Pharma IQ


comments powered by Disqus


Advertise With Us

Join the Pharmas IQ Community